Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California San Francisco, shared a post on X/Twitter:
“Just out in Blood Advances: We estimate how many people are eligible for CAR-T.
The answer: Best case scenario 3.9%, and <2% of cancer patients respond.”
Further details.
Source: Vinay Prasad/X